Results 201 to 210 of about 168,165 (319)

CCL20/CXCL5 Drives Crosstalk Between Anaplastic Thyroid Cancer Stem Cells and Tumor‐Associated Macrophages to Promote Tumor Progression

open access: yesAdvanced Science, EarlyView.
This study elucidates the crosstalk between tumor‐associated macrophages (TAMs) and anaplastic thyroid cancer stem cells (ATCSCs). The findings reveal that CCL20 from THP‐1‐M2 activates the IRAK‐1/NF‐κB1/2 pathway in ATCSCs, thereby enhancing CXCL5 secretion.
Qi Liu   +11 more
wiley   +1 more source

BACK-TRANSPLANTATION FOR SURVIVAL OF THE GRAFT

open access: yesTransplantation, 2004
Kiyoshi Fukunaga   +2 more
openaire   +3 more sources

THE IMPACT OF HLA MATCHING ON GRAFT SURVIVAL AND ON SENSITIZATION AFTER A FAILED TRANSPLANT

open access: bronze, 1990
Arthur J. Matas   +8 more
openalex   +1 more source

The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients [PDF]

open access: bronze, 1998
Russell H. Wiesner   +5 more
openalex   +1 more source

Inhalable Hsa‐miR‐30a‐3p Liposomes Attenuate Pulmonary Fibrosis

open access: yesAdvanced Science, EarlyView.
The study explores inhalable hsa‐miR‐30a‐3p‐loaded liposomes as a treatment for bleomycin‐induced pulmonary fibrosis in mice. Hsa‐miR‐30a‐3p is electroporated into liposomes and formulated into a dry powder for inhalation. Delivered via dry powder inhalation, it improves pulmonary function, promotes myofibroblast de‐differentiation by targeting CNPY2 ...
Shuo Liu   +14 more
wiley   +1 more source

MOLECULAR COMPATIBILITY AND RENAL GRAFT SURVIVAL—THE HLA DRB1 GENOTYPING1

open access: bronze, 1993
SHYUAN HSIA   +6 more
openalex   +1 more source

Renal graft survival in native and non-native European recipients [PDF]

open access: bronze, 1999
Joke I. Roodnat   +6 more
openalex   +1 more source

Targeting KMT5C Suppresses Lung Cancer Progression and Enhances the Efficacy of Immunotherapy

open access: yesAdvanced Science, EarlyView.
This study reveals that KMT5C activates DNA damage repair to inhibit STING‐IRF3 pathway, downstream type I IFN signaling and CCL5 secretion, leading to the downregulation of CD8+ T cell infiltration and function in NSCLC, ultimately facilitating tumor progression.
Yunfeng Yuan   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy